1.
Flythe JE,Mc Causland FR. Dialysate sodium: rationale for evolution over time. Semin Dial. 2017;30(2):99-111.doi:10.1111/sdi.12570
2.
Zoccali C, Mallamaci F, Tirpepi G. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol Dial Transplant. 2004;19(5):67-72. doi:10.1093/ndt/gfh1059
3.
Stenvinkel P. Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant. 2002;17(8):33-38. doi:10.1093/ndt/17.suppl_8.33
4.
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648-658. doi:10.1046/j.1523-1755.1999.00273.x
5.
Zimmermann J, Schramm L, Metzger T, Wanner C. Malnutrition, inflammation, and atherosclerosis in chronic renal insufficiency. Nieren- und Hochdruckkrankhelten. 2003;32(9):401-407. doi:10.5414/nhp32401
6.
Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16(6):1189-1197. doi:10.1093/ndt/16.6.1189
7.
Wenzel UO, Bode M, Kurts C, Ehmke H. Salt, inflammation, IL-17 and hypertension. Br J Pharmacol. 2019;176(12):1853-1863. doi:10.1111/bph. 14359
8.
Macunluoglu B, Gumrukcuoglu HA, Atakan A. Lowering dialysate sodium improves systemic oxidative stress in maintenance hemodialysis patients.Int Urol Nephrol. 2016;48(10):1699-1704. doi:10.1007/s11255-016-1367-z
9.
Gumrukcuoglu HA, Arı E, Akyol A. Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients.Int Urol Nephrol. 2012;44(6):1833-1839. doi:10.1007/s11255-011-0117-5
10.
Dunlop JL, Vandal AC, Marshall MR. Low dialysate sodium levels for chronic haemodialysis.Cochrane Database Syst Rev. 2019;1(1):CD011204. doi:10.1002/14651858.CD011204.pub2
11.
Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
12.
Stenvinkel P, Wanner C, Metzger T.Inflammation, and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int.2002;62(5):1791-1798. doi:10.1046/j.1523-1755.2002.00637.x
13.
Carrero JJ, Stenvinkel P.Inflammation in end-stage renal disease-what have we learned in 10 years? Semin Dial. 2010;23(5):498-509. doi:10.1111/j.1525-139X.2010.00784.x
14.
Drukker W, Parsons FM, Maher JF. A textbook of dialysis.Boston, MA: Kluwer Boston Inc; 1983.
15.
Munoz Mendoza J, Arramreddy R, Schiller B. Dialysate sodium: choosing the optimal hemodialysis bath. Am J Kidney Dis. 2015;66(4):710-720. doi:10.1053/j.ajkd.2015.03.034
16.
Munoz Mendoza J, Sun S, Chertow GM, Moran J, Doss S, Schiller B. Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?Nephrol Dial Transplant.2011;26(4):1281-1287. doi:10.1093/ndt/gfq807
17.
Basile C, Pisano A, Lisi P, Rossi L, Lomonte C, Bolignano D. High versus low dialysate sodium concentration in chronic haemodialysis patients: a systematic review of 23 studies. Nephrol Dial Transplant. 2016;31(4):548-563. doi:10.1093/ndt/gfv084
18.
18. Hanafusa N,Tsuchiya K,Nitta K. Treatment considerations in conventional hd-what we know. Dialysate sodium concentration: the forgotten saltshaker. Semin Dial. 2018;31(6):563-568. doi:10.1111/sdi. 12749
19.
Kutlugün A, Erdem Y, Okutucu S, Yorgun H, Atalar E, Arici M. Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease.Nephrol Dial Transplant. 2011;26(11):3678-3682. doi:10.1093/ndt/gfr092
20.
Levin A, Goldstein MB. The benefits and side effects of ramped hypertonic sodium dialysis. J Am Soc Nephrol. 1996;7(2):242-246. doi: 10.1681/ASN.V72242
21.
Zwiech R, Bruzda-Zwiech A. The dual blockade of the renin-angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration. Int Urol Nephrol. 2013;45(5):1365-1372. doi:10.1007/s11255-012-0320-z
22.
Manlucu J, Gallo K, Heidenheim PA, Lindsay RM. Lowering post dialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system. Am J Kidney Dis. 2010;56 (1):69-76. doi:10.1053/j.ajkd. 2009.12.037.2006;98:1283-7
23.
Tang HL, Wong SH, Chu KH, et al. Sodium ramping reduces hypotension and symptoms during hemodialysis. Hong Kong Med J. 2006;12(1):10-14.
24.
Del Giudice A, Cicchella A, Di Giorgio G, et al. Prevalence and control of hypertension in chronic hemodialysis patients: results of a single-centre clinical audit. G Ital Nefrol. 2012;29(2):230-237.
25.
Kanwar M, Hashem M, Rosman H, et al. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.Am J Cardiol. 2006;98(9):1283-1287. doi:10.1016/j.amjcard.2006.05.064
26.
Meuwese CL, Halbesma N, Stenvinkel P, et al. Variations in C-reactive protein during a single haemodialysis session do not associate with mortality.Nephrol Dial Transplant. 2010;25(11):3717-3723. doi:10.1093/ndt/gfq273
27.
Hecking M, Karaboyas A, Saran R, et al. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the dialysis outcomes and practice patterns study (DOPPS).Am J Kidney Dis. 2012;59(2):238-248. doi:10.1053/j.ajkd.2011.07.013
28.
Lakshmi BS , Devi NH, Suchitra MM ,Srinivasa Rao PVLN, Kumar VS. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease. Ren Fail. 2018;40(1):534-540. doi:10.1080/0886022X.2018.1487857